Annabelle Friedrich

448 total citations · 1 hit paper
8 papers, 306 citations indexed

About

Annabelle Friedrich is a scholar working on Molecular Biology, Epidemiology and Biotechnology. According to data from OpenAlex, Annabelle Friedrich has authored 8 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Biotechnology. Recurrent topics in Annabelle Friedrich's work include Autophagy in Disease and Therapy (3 papers), Microbial Metabolism and Applications (2 papers) and Epigenetics and DNA Methylation (2 papers). Annabelle Friedrich is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Microbial Metabolism and Applications (2 papers) and Epigenetics and DNA Methylation (2 papers). Annabelle Friedrich collaborates with scholars based in Germany, Italy and Russia. Annabelle Friedrich's co-authors include David Schlütermann, Björn Stork, María José Mendiburo, Lena Berning, Wenxian Wu, Jana Deitersen, Niklas Berleth, Yadong Sun, Fabian Stuhldreier and Carsten Berndt and has published in prestigious journals such as Molecular Cell, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Annabelle Friedrich

8 papers receiving 305 citations

Hit Papers

Fin56-induced ferroptosis is supported by autophagy-media... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annabelle Friedrich Germany 6 194 160 129 70 25 8 306
Lena Berning Germany 6 190 1.0× 160 1.0× 127 1.0× 50 0.7× 13 0.5× 8 296
Dannah Miller United States 8 208 1.1× 74 0.5× 97 0.8× 113 1.6× 23 0.9× 15 323
Yunjie Chu China 6 241 1.2× 195 1.2× 167 1.3× 29 0.4× 11 0.4× 7 403
Juan Zou China 13 241 1.2× 75 0.5× 147 1.1× 29 0.4× 19 0.8× 36 416
Liangliang Dong China 11 305 1.6× 97 0.6× 216 1.7× 21 0.3× 10 0.4× 25 420
Alison Bamberg United States 5 137 0.7× 72 0.5× 31 0.2× 135 1.9× 42 1.7× 5 279
Ghader Babaei Iran 4 275 1.4× 48 0.3× 149 1.2× 50 0.7× 26 1.0× 5 399
Christine Yim‐Ping Wong Hong Kong 11 252 1.3× 65 0.4× 163 1.3× 20 0.3× 9 0.4× 18 388
N. Wake United Kingdom 6 217 1.1× 66 0.4× 46 0.4× 28 0.4× 46 1.8× 6 301

Countries citing papers authored by Annabelle Friedrich

Since Specialization
Citations

This map shows the geographic impact of Annabelle Friedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annabelle Friedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annabelle Friedrich more than expected).

Fields of papers citing papers by Annabelle Friedrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annabelle Friedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annabelle Friedrich. The network helps show where Annabelle Friedrich may publish in the future.

Co-authorship network of co-authors of Annabelle Friedrich

This figure shows the co-authorship network connecting the top 25 collaborators of Annabelle Friedrich. A scholar is included among the top collaborators of Annabelle Friedrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annabelle Friedrich. Annabelle Friedrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Friedrich, Annabelle, Lorenz Sellin, Björn Stork, et al.. (2024). Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21WAF1/CIP1 proteasomal degradation in senescent cells. Cell Death and Disease. 15(5). 373–373. 3 indexed citations
2.
Berning, Lena, Thomas Lenz, Gereon Poschmann, et al.. (2023). The Golgi stacking protein GRASP55 is targeted by the natural compound prodigiosin. Cell Communication and Signaling. 21(1). 275–275. 4 indexed citations
3.
Nguyen, Anh, Annabelle Friedrich, David Schlütermann, et al.. (2023). Metamorphic proteins at the basis of human autophagy initiation and lipid transfer. Molecular Cell. 83(12). 2077–2090.e12. 26 indexed citations
4.
Berning, Lena, David Schlütermann, Annabelle Friedrich, et al.. (2021). Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment. Molecules. 26(5). 1294–1294. 14 indexed citations
5.
Sun, Yadong, Niklas Berleth, Wenxian Wu, et al.. (2021). Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell Death and Disease. 12(11). 1028–1028. 210 indexed citations breakdown →
6.
Deitersen, Jana, Lena Berning, Fabian Stuhldreier, et al.. (2021). High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol. Cell Death and Disease. 12(6). 560–560. 12 indexed citations
7.
Schlütermann, David, Niklas Berleth, Jana Deitersen, et al.. (2021). FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates. Scientific Reports. 11(1). 13863–13863. 28 indexed citations
8.
Friedrich, Annabelle, Matthias U. Kassack, Wolfgang A. Schulz, et al.. (2020). In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi). International Journal of Molecular Sciences. 21(13). 4747–4747. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026